NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

False increases of troponin I attributable to incomplete separation of serum.

Author(s): Nosanchuk JS, Combs B, Abbott G

Publication: Clin Chem, 1999, Vol. 45, Page 714

PubMed ID: 10222366 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of recentrifugation and collection of plasma instead of serum on troponin I levels using the AxSYM assay.

Conclusion of Paper

Initial levels of Troponin I were higher in serum than in plasma, however, after serum was centrifuged a second time, the troponin I levels were the same as in plasma.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of recentrifugation and collection of plasma instead of serum on troponin I levels using the AxSYM assay.

    Summary of Findings:

    Initial levels of Troponin I were higher in serum than in plasma, however, after serum was centrifuged a second time, the troponin I levels were the same as in plasma. The authors believe the antibody used in the AxSYM assay may interact with fibrin resulting in falsely high Troponin I levels when serum separation is incomplete.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Not specified
    Platform:
    AnalyteTechnology Platform
    Protein Clinical chemistry/auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Blood and blood products Plasma
    Serum
    Biospecimen Aliquots and Components Centrifugation Different number of centrifugation steps compared

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...